News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
32,632 Results
Type
Article (1017)
Company Profile (1)
Press Release (31614)
Section
Business (14781)
Career Advice (92)
Deals (1857)
Drug Development (3552)
Employer Resources (1)
FDA (551)
Job Trends (813)
News (19840)
Policy (850)
Tag
Academia (32)
Allergies (3)
Alliances (1266)
ALS (3)
Alzheimer's disease (33)
Antibody-drug conjugate (ADC) (5)
Approvals (568)
Artificial intelligence (4)
Automation (1)
Bankruptcy (8)
Best Places to Work (742)
Biosimilars (2)
Bladder cancer (5)
Breast cancer (21)
Cancer (100)
Cardiovascular disease (16)
Career advice (76)
CAR-T (6)
Cell therapy (10)
Cervical cancer (1)
Clinical research (2946)
Collaboration (13)
Compensation (5)
COVID-19 (66)
CRISPR (1)
C-suite (2)
Cystic fibrosis (2)
Data (154)
Depression (2)
Diabetes (10)
Diagnostics (314)
Digital health (1)
Drug discovery (1)
Drug pricing (1)
Duchenne muscular dystrophy (4)
Earnings (12950)
Editorial (1)
Employer resources (1)
Events (5713)
Executive appointments (3)
FDA (641)
Funding (10)
Gene editing (5)
Generative AI (1)
Gene therapy (13)
GLP-1 (19)
Government (88)
Guidances (47)
Healthcare (854)
Huntington's disease (1)
IgA nephropathy (2)
Immunology and inflammation (5)
Indications (3)
Infectious disease (70)
Inflammatory bowel disease (11)
Influenza (1)
Intellectual property (3)
Interviews (19)
IPO (1411)
Job creations (115)
Job search strategy (60)
Labor market (1)
Layoffs (8)
Legal (124)
Liver cancer (4)
Lung cancer (14)
Lymphoma (14)
Machine learning (1)
Manufacturing (2)
MASH (3)
Medical device (763)
Medtech (763)
Mergers & acquisitions (453)
Metabolic disorders (21)
Multiple sclerosis (3)
Neurodegenerative disease (1)
Neuropsychiatric disorders (3)
Neuroscience (50)
NextGen: Class of 2025 (214)
Non-profit (96)
Obesity (8)
Ovarian cancer (2)
Pain (2)
Pancreatic cancer (2)
Parkinson's disease (3)
Patents (7)
Patient recruitment (1)
Peanut (3)
People (981)
Phase I (873)
Phase II (1194)
Phase III (1077)
Pipeline (232)
Postmarket research (149)
Preclinical (430)
Prostate cancer (3)
Radiopharmaceuticals (16)
Rare diseases (12)
Real estate (129)
Recruiting (1)
Regulatory (699)
Reports (1)
Research institute (61)
Resumes & cover letters (17)
RSV (1)
Schizophrenia (5)
Series A (4)
Series B (3)
Sickle cell disease (5)
Startups (63)
Tariffs (1)
The Weekly (1)
Vaccines (11)
Venture capitalists (1)
Weight loss (1)
Women's health (1)
Date
Today (7)
Last 7 days (100)
Last 30 days (205)
Last 365 days (1895)
2025 (662)
2024 (2278)
2023 (2602)
2022 (3013)
2021 (3011)
2020 (2634)
2019 (2078)
2018 (1364)
2017 (1144)
2016 (719)
2015 (1167)
2014 (745)
2013 (537)
2012 (603)
2011 (568)
2010 (5676)
Location
Africa (31)
Arizona (7)
Asia (1778)
Australia (218)
California (404)
Canada (122)
China (19)
Colorado (20)
Connecticut (15)
Delaware (18)
Europe (4697)
Florida (50)
Georgia (14)
Idaho (2)
Illinois (34)
Indiana (23)
Japan (6)
Kansas (3)
Louisiana (4)
Maine (13)
Maryland (41)
Massachusetts (269)
Michigan (12)
Minnesota (29)
Missouri (2)
Montana (1)
Nevada (6)
New Hampshire (5)
New Jersey (111)
New York (101)
North Carolina (54)
Northern California (215)
Ohio (15)
Pennsylvania (82)
Puerto Rico (1)
South America (56)
Southern California (143)
Tennessee (4)
Texas (31)
United States (1390)
Utah (17)
Virginia (4)
Washington State (33)
Wisconsin (2)
32,632 Results for "123".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Innate Pharma Regains Its Rights on CD123 Targeting ANKET® and Announces Sanofi’s Intention to Make a Strategic Investment in the Company
April 23, 2025
·
7 min read
Press Releases
Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion
February 21, 2025
·
10 min read
Press Releases
Complement 3 Glomerulopathy Market Size to Reach USD 12.3 Billion by 2035, Impelled by Advancements in Targeted Drug Therapies
January 29, 2025
·
12 min read
Cell-Free RNA Isolation and Extraction Kits Market Reach USD123.94 Million by 2031
Global Cell-Free RNA Isolation & Extraction Kits Market is valued at US$ 41.55 Mn in 2023, and it is expected to reach US$ 123.94 Mn by 2031, with a CAGR of 14.90% during the forecast period of 2024-2031.
April 17, 2024
·
4 min read
Policy
Curium Announces Ioflupane I 123 Injection Availability for Friday Patient Use
Curium announced that beginning Friday, April 5, 2024, Ioflupane I 123 Injection will be available for Friday patient administration in the US. This additional day of production allows customers to access the product and capitalize on early morning availability on a day not previously available from Curium.
February 6, 2024
·
5 min read
Drug Development
Grace Science, LLC Announces First Patient Treated in Phase 1/2/3 Trial of GS-100, an AAV9 Gene Therapy for NGLY1 Deficiency
Grace Science, LLC announced today that the first patient was dosed in an open-label Phase 1/2/3 clinical trial of GS-100, an AAV9 gene replacement therapy for the treatment of NGLY1 Deficiency.
March 5, 2024
·
2 min read
Press Releases
TORL BioTherapeutics Announces Appointment of Aran Maree, M.D., as Chief Medical Officer and Initiates TORL-1-23 Registration-Enabling Phase 2 Study in Platinum-Resistant Ovarian Cancer
December 2, 2024
·
6 min read
Press Releases
TILT Biotherapeutics Presents Clinical Data on TILT-123 After Fully Intravenous Delivery Regimen at ESMO 2024
September 9, 2024
·
3 min read
Press Releases
NeuroTherapia Raises $12.3M in the First Close of its Series B Financing
August 7, 2024
·
4 min read
Press Releases
Genethon Presents Positive Initial Results from a Phase 1/2/3 Trial of its Gene Therapy (GNT0004) for Duchenne Muscular Dystrophy at ASGCT Breakthroughs in Muscular Dystrophy in Chicago
November 19, 2024
·
5 min read
1 of 3,264
Next
